Accelerating Medical Treatments for Serious Mental Illness
President Donald Trump signed it on April 18, 2026. Published in the Federal Register on April 22, 2026, 91 FR 21709.
What this order does
Not checked yetPlain-language account: Not checked yet. A draft is written and a person has not finished reviewing it.
On the record
On the record: Not started.
Press releases by members of Congress
From a secondary sourceThese are press releases from members' official websites that name this order. We save a copy of each one.
5 press releases
-
“President Trump’s recent Executive Order, entitled “Accelerating Medical Treatments for Serious Mental Illness,” articulates the imperative to hasten research efforts, stating, “It is the policy of my Administration to accelerate innovative research models and appropriate drug approvals to increase access to psychedelic drugs that could save lives and reverse the crisis of serious mental illness in America.” As psychedelics are”
-
“This legislation would codify President Donald J. Trump’s Executive Order No. 14401, which accelerates the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States.”
-
“This legislation would codify President Donald J. Trump’s Executive Order No. 14401, which works to expand access to innovative, neuroplastogen treatments that could accelerate the healing process for veterans struggling with mental health and substance addictions.”
-
“This legislation would codify President Donald J. Trump’s Executive Order No. 14401, which accelerates the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States.”
-
Bergman, Correa Lead Letter Urging FDA to Expedite Review of Breakthrough Mental Health Therapies
“The letter follows President Trump’s April 18 signing of the Executive Order “Accelerating Medical Treatments for Serious Mental Illness,” which directs federal agencies to fast-track access to psychedelic treatments for patients with serious mental illnesses who have not found relief in existing treatment options.”
Read from 539 of 539 members' sites, releases since January 3, 2025, through November 22, 2026.
Press releases by organizations
No saved press release from these organizations names this order.
Read from 437 of 437 organizations' sites, releases since January 3, 2025, through November 22, 2026.
Agencies the Federal Register lists for this order
Where this comes from
We saved our own copy of the Federal Register's file for this order before writing this page. A code beside a file is its fingerprint, a short code that changes if the file's contents change.